See more : Feng Tay Enterprises Co., Ltd. (9910.TW) Income Statement Analysis – Financial Results
Complete financial analysis of Valiant Organics Limited (VALIANTORG.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Valiant Organics Limited, a leading company in the Chemicals industry within the Basic Materials sector.
- Uniti S.A (ALUNT.PA) Income Statement Analysis – Financial Results
- Toshiba Corporation (TOSYY) Income Statement Analysis – Financial Results
- Dimeco, Inc. (DIMC) Income Statement Analysis – Financial Results
- View United Real Estate Development Co. (9591.SR) Income Statement Analysis – Financial Results
- CP ALL Public Company Limited (CPALL-R.BK) Income Statement Analysis – Financial Results
Valiant Organics Limited (VALIANTORG.NS)
About Valiant Organics Limited
Valiant Organics Limited, a chemical manufacturing company, manufactures and markets specialty chemicals in India. Its products include para chlorophenol; ortho chlorophenol; 2,4 di-chlorophenol; 2,4,6 tri- chlorophenol; 2,6 di-chlorophenol; and para nitroaniline. The company's products also comprise ortho chloro para nitro aniline, 6 acetyl OAPSA, OA acetanilide, and PA acetanilide; ortho anisidine, para anisidine, ortho toluidine, para toluidine, IPPCA, FI aniline, and meta chloro aniline; acids; para and ortho amino phenol; and ortho and para nitro anisole. Its products are primarily used as intermediates in agro chemicals, dyes, pigments, pharmaceuticals, cosmetics, specialty chemicals, polymer, and veterinary drugs. The company also exports its products to Europe, Asia, and the United States. Valiant Organics Limited was founded in 1984 and is based in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.23B | 10.52B | 11.53B | 7.55B | 6.75B | 6.92B | 1.21B | 579.90M | 520.99M | 590.38M | 425.10M | 339.95M | 326.77M |
| Cost of Revenue | 6.76B | 6.88B | 8.13B | 4.41B | 4.59B | 4.79B | 850.33M | 379.54M | 251.18M | 371.56M | 257.25M | 202.31M | 180.07M |
| Gross Profit | 470.01M | 3.63B | 3.41B | 3.13B | 2.16B | 2.13B | 356.12M | 200.36M | 269.82M | 218.82M | 167.85M | 137.64M | 146.70M |
| Gross Profit Ratio | 6.50% | 34.54% | 29.54% | 41.52% | 32.04% | 30.84% | 29.52% | 34.55% | 51.79% | 37.07% | 39.48% | 40.49% | 44.89% |
| Research & Development | 10.00M | 7.47M | 5.02M | 2.52M | 2.37M | 1.75M | 1.10M | 808.24K | 186.99K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 74.29M | 74.45M | 57.21M | 53.74M | 44.60M | 47.68M | 9.32M | 17.13M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 137.90M | 173.26M | 182.92M | 134.93M | 71.89M | 70.53M | 29.85M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 503.22M | 247.70M | 240.12M | 188.67M | 116.48M | 118.21M | 39.17M | 17.13M | 88.85M | 21.42M | 17.89M | 11.65M | 0.00 |
| Other Expenses | 0.00 | 80.33M | 35.75M | 28.65M | 30.94M | 14.94M | -3.52M | -2.39M | 119.24M | 114.12M | 93.99M | 85.53M | 88.88M |
| Operating Expenses | 509.44M | 2.28B | 1.61B | 1.27B | 502.25M | 436.18M | 109.78M | 48.34M | 119.24M | 114.12M | 93.99M | 85.53M | 88.88M |
| Cost & Expenses | 7.23B | 9.17B | 9.74B | 5.68B | 5.09B | 5.22B | 960.11M | 427.88M | 370.42M | 485.67M | 351.24M | 287.84M | 268.94M |
| Interest Income | 1.60M | 3.94M | 8.52M | 14.53M | 3.20M | 5.19M | 1.93M | 266.42K | 1.01M | 407.00K | 534.00K | 142.00K | 236.00K |
| Interest Expense | 163.43M | 107.93M | 64.79M | 49.98M | 22.42M | 35.41M | 1.11M | 542.61K | 4.85M | 6.18M | 5.88M | 3.81M | 3.53M |
| Depreciation & Amortization | 349.25M | 291.89M | 296.19M | 212.40M | 157.67M | 136.41M | 21.88M | 17.09M | 9.27M | 8.19M | 7.85M | 7.38M | 8.89M |
| EBITDA | 425.75M | 1.77B | 2.12B | 2.11B | 1.87B | 1.89B | 265.38M | 189.89M | 171.64M | 111.72M | 81.71M | 71.71M | 71.84M |
| EBITDA Ratio | 5.89% | 16.38% | 18.44% | 27.99% | 27.43% | 26.94% | 22.41% | 28.09% | 30.68% | 18.92% | 19.13% | 17.50% | 20.38% |
| Operating Income | 0.00 | 1.36B | 1.76B | 1.87B | 1.68B | 1.70B | 246.34M | 154.12M | 157.52M | 109.36M | 81.99M | 60.51M | 59.42M |
| Operating Income Ratio | 0.00% | 12.89% | 15.27% | 24.80% | 24.93% | 24.54% | 20.42% | 26.58% | 30.23% | 18.52% | 19.29% | 17.80% | 18.18% |
| Total Other Income/Expenses | -86.93M | -1.57B | -1.45B | -1.13B | 33.77M | 20.52M | 6.00M | 7.55M | -1.75M | -88.04M | 8.12M | 8.40M | -1.00K |
| Income Before Tax | -86.93M | 1.37B | 1.76B | 1.85B | 1.83B | 1.71B | 252.34M | 151.72M | 157.52M | 109.36M | 81.98M | 60.51M | 59.42M |
| Income Before Tax Ratio | -1.20% | 13.04% | 15.28% | 24.49% | 27.08% | 24.73% | 20.92% | 26.16% | 30.23% | 18.52% | 19.29% | 17.80% | 18.18% |
| Income Tax Expense | -2.97M | 346.16M | 482.57M | 539.90M | 422.69M | 499.64M | 88.96M | 53.38M | 54.46M | 36.63M | 26.57M | 20.25M | 20.24M |
| Net Income | -83.91M | 881.21M | 1.13B | 1.15B | 1.24B | 1.33B | 163.38M | 98.34M | 103.06M | 72.73M | 55.41M | 40.26M | 39.18M |
| Net Income Ratio | -1.16% | 8.38% | 9.82% | 15.18% | 18.36% | 19.25% | 13.54% | 16.96% | 19.78% | 12.32% | 13.04% | 11.84% | 11.99% |
| EPS | -3.04 | 32.45 | 41.72 | 44.68 | 25.50 | 48.32 | 13.93 | 9.90 | 14.07 | 9.99 | 7.61 | 5.53 | 5.38 |
| EPS Diluted | -3.04 | 31.50 | 40.51 | 40.97 | 22.16 | 48.32 | 13.93 | 9.90 | 14.07 | 9.99 | 7.61 | 5.53 | 5.38 |
| Weighted Avg Shares Out | 27.58M | 27.58M | 27.58M | 27.58M | 27.58M | 27.58M | 27.58M | 27.58M | 27.58M | 27.58M | 27.58M | 27.58M | 27.58M |
| Weighted Avg Shares Out (Dil) | 27.58M | 27.58M | 27.58M | 27.58M | 27.58M | 27.58M | 27.58M | 27.58M | 27.58M | 27.58M | 27.58M | 27.58M | 27.58M |
Source: https://incomestatements.info
Category: Stock Reports